Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-30 @ 10:00 PM
Study NCT ID:
NCT05073133
Status:
COMPLETED
Last Update Posted:
2024-10-09
First Post:
2021-09-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-20
First Submit QC Date:
None
Study First Post Date:
2021-10-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-15
Results First Submit QC Date:
None
Results First Post Date:
2024-05-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL